Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Related Posts Sarama Files Memorial in US$242M Damages Claim Against Burkina Faso November 3, 2025 RUA GOLD Engages ICP Securities Inc. for Automated Market Making Services November 3, 2025 Anteros Metals Inc. Announces Closing of First Tranche of Private Placement November 3, 2025